# Launchpad Therapeutics, Inc. — Form D

Launchpad Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-30. The offering totals $30.0M, of which $10.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-12-30
- Form: D
- Accession: 0001959206-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $30.0M
- Amount sold: $10.0M
- Remaining: $20.0M
- Investors: 3
- Date of first sale: 2022-12-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-469187

## Issuer

- Name: Launchpad Therapeutics, Inc.
- CIK: 0001959206
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA, 02142
- Phone: 617-252-0848

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Ali Behbahani | Director | Littleton, CO |
| Alexander Mayweg | Director | South San Francisco, CA |
| Anna Kohlmann | Executive Officer | CAMBRIDGE, MA |
| Alexander Mayweg | Executive Officer | South San Francisco, CA |

## More

- [CIK 1959206 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1959206&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001959206-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.